EpiCept News
Most Popular EpiCept Story
EpiCept shares hammered after FDA rejects app, demands new trial
Shares of EpiCept (EPCT) cratered this morning after the developer announced that the FDA had handed back its NDA on a new therapy for AML, saying that it needed to mount a new pivotal trial in order Read more...
Latest Headlines
- January 12, 2009
- April 19, 2007
- September 5, 2006
- September 5, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
